Pfl55 is a merozoite-derived polypeptide antigen which the parasite Plasmodium falciparum deposits in the membranes of erythrocytes at invasion. Eleven laboratory strains or clones of P. falciparum and a large number of isolates obtained from patients from different parts of the world were studied for antigenic diversity in Pfl55. Immunoglobulin G antibodies from different serum samples from P. falciparum-infected donors were affinity purified on monolayers of glutaraldehyde-fixed and air-dried erythrocytes infected with P. falkiparum of different origins and tested in different combinations by immunoblotting, reinvasion inhibition, and a modified immunofluorescence procedure in which the membranes of recently infected erythrocytes were stained. Similar experiments were performed with monoclonal and oligoclonal antibodies specific for different epitopes in the C-terminal region of Pfl55. No strain-or isolate-associated antigenic diversity or size variation of Pfl55 was detected, indicating that the immunodominant regions of this antigen are highly conserved throughout the world.
Pfl55 is a merozoite-derived, heat-stable polypeptide (Mr, 155,000) which the human malaria parasite Plasmodium falciparum deposits in the membranes of erythrocytes at invasion (28) . It is identical with ring-infected erythrocyte surface antigen (RESA) which has been described recently by others (11) . Like several other P. falciparum antigens, Pfl55 contains stretches of tandemly repeated amino acid sequences which are strongly antigenic in naturally infected humans (24, 27) . The appearance of anti-Pfl55 antibodies correlates well with the acquisition of clinical immunity (38) , and these antibodies also very efficiently inhibit reinvasion of erythrocytes by P. falciparum merozoites in vitro (39) . Thus, Pfl55 may be an important candidate for a vaccine against the asexual blood stages of this malaria parasite. This is also supported by results of a recent vaccination trial in Aotus monkeys (10) .
To be used for a vaccine, the immunodominant structures of an antigen should be invariant. Several of the plasmodial antigens detected on the surface of infected erythrocytes or on schizonts and merozoites exhibit a strain-and isolateassociated diversity (25, 27) or even antigenic variation (20, 21) , probably obviating their usefulness as vaccine components. Results of preliminary serological studies of Pfl55 have given no indications of antigenic diversity (28) . Similarly, results of limited studies at the DNA level also suggest that the major antigenic structures of this immunogen are conserved in different P. falciparum strains (18) . Results of more extensive experiments establishing the absence of antigenic diversity of Pfl55, however, have not heretofore been reported. Here we report our results of an investigation of the reaction of Pfl55 from a large number of P. falciparurn strains, clones, or fresh isolates with a variety of antibodies. No strain-or isolate-associated antigenic diversity or size variation of Pfl55 was detected.
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MATERIALS AND METHODS
Parasites. The parasites (P. falciparum) used in these experiments either were from cultured laboratory strains (34) or were isolates obtained from patients. These isolates were prepared for microscopic investigation without in vitro culturing. The following laboratory strains or cloned lines were used: F32 (Tanzania [23] ); K1 (Thailand [31] ); Thail (Thailand; established in 1985 from a chloroquine-resistant isolate of a Swedish patient (patient N) by A. Bjorkman, Stockholm); T9, clone 96 (Thailand [33] ); CDC1, clone HB3 (Honduras [6] ); IMTM22, clone 7G8 (Brazil [16] ). Three additional strains (Honduras, Kenya, and Tanzania) were kindly provided by R. Nussenzweig, New York, N.Y. Two strains, FCR1/FVO (Vietnam) and FCR3/FMG (Gambia [35] ), were obtained from the blood of Aotus trivirgatus monkeys. Isolates from patients were obtained from 11 Liberian and 9 Colombian donors who had repeated P. falciparum infections. Six isolates were from Swedish donors who had acquired their infections in Kenya (n = 3), Zaire (n = 1), India (n = 1), and Thailand (n = 1). Freshly drawn blood (parasitemias, usually 2 to 10%) was washed three to four times with Tris-buffered Hanks solution, diluted to 1% suspensions, and layered on eight-well multitest slides for microscopic examination (28) .
Immune sera. Human immune sera were obtained from Swedish or South American patients who had acute P. falciparuin infections or from African blood donors living in an area of Liberia with high levels of P. falciparum transmission (7). Most donors had a history of repeated P. falciparum infections or were clinically immune to the disease.
Rabbit antiserum to the synthetic dimer of the tetrapeptide Glu-Glu-Asn-Val, a sequence that is repeated approximately 30 times in the C-terminal end of Pf155 (14, 18) , were obtained by immunizing rabbits with this peptide coupled to keyhole limpet hemocyanin, as described elsewhere (3 Preparation and purification of these antibodies have been described previously (36) .
Affinity purification of antibodies on monolayers of infected erythrocytes. For enrichment of antibodies to Pfl55, serum or IgG fractions were adsorbed to monolayers of glutaraldehyde-fixed and air-dried erythrocytes in Petri dishes (parasitemias, 5 to 10%). The supernatants with nonadsorbed IgG were added sequentially to fresh monolayers in some experiments until they were free of Pfl55 antibodies as detected by indirect immunofluorescence on monolayers of glutaraldehyde-fixed and air-dried P. falciparum-infected erythrocytes. After the plates were washed, the antibodies that adsorbed to the membranes of infected erythrocytes were isolated by acid elution (pH 2.8) and immediately neutralized (28) .
Determination of immunoglobulin. Immunoglobulin in serum or in various antibody preparations was determined by a sandwich enzyme-linked immunosorbent assay (17) . Anti-F(ab')2 antibodies from a rabbit anti-human immunoglobulin serum sample were used to coat the microplates. Serial dilutions of the test samples and a known IgG standard (five dilutions) were then added as described previously (40 40 ,000 erythrocytes that were screened. The 50% inhibition titers were calculated from titration curves obtained by using at least four different concentrations of the inhibitory immunoglobulin.
Immunoblotting. Merozoite-enriched fractions of in vitrocultured parasites were prepared from spent culture medium as described previously (28) . The polypeptides of merozoite lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions, electrophoretically transferred to nitrocellulose, and probed with the various antibody preparations. Bound antibodies were detected with alkaline phosphatase-conjugated anti-immunoglobulin reagents and by staining for alkaline phosphatase (3, 5, 28) . Molecular weight markers were obtained from Bio-Rad Laboratories, Richmond, Calif.
RESULTS
Titers of different human serum samples by the EMIF assay. Pfl55 in the membranes of ring-infected erythrocytes is most easily detected by indirect immunofluorescence after short glutaraldehyde fixation and drying of erythrocyte monolayers (28) . The results of a typical experiment in which 13 different serum samples from malaria-exposed donors were analyzed in the EMIF assay on erythrocytes (Fig. 2) .
The Reinvasion inhibition by affinity-purified human antibodies. To establish the biological activity of the anti-Pfl55 antibodies which bind to different parasites, IgG fractions were affinity purified and tested for reinvasion inhibition in vitro (39) . When purified on F32, such antibody preparations have previously been shown to give complete and dose-dependent reinvasion inhibition of this parasite and to have much higher inhibitory titers than the total IgG fractions from which they were derived. Results of an experiment in which IgG from the serum of the Liberian donor A was affinity purified on erythrocytes infected with F32, Ki, or IMTM22/7G8 and tested for reinvasion inhibition in the F32 system are shown in Table 3 . Both the total IgG fraction and the three affinity-purified preparations completely inhibited reinvasion in a dose-dependent fashion (data not shown). The 50% inhibition titer of the affinity-purified antibodies was approximately 30 times higher than that of the original IgG fraction and was similar for all three preparations (Table 3) , suggesting that the F32-inhibitory antibodies were of similar specificity. After absorption on erythrocytes infected with these different parasite strains, the IgG fractions retained a reinvasion-inhibitory activity, although this was approximately 50 times less than that of the affinity-purified antibodies. As these IgG fractions had lost their activity in the EMIF assay, they were probably depleted of anti-Pfl55 antibodies, suggesting that their residual inhibitory activity was due to antibodies to other parasite antigens than Pfl55.
The results of an experiment in which the inhibitory activity of affinity-purified antibodies of the Liberian donor A was compared with that of the Colombian donor D, whose total IgG also gave complete inhibition, are shown in Table  4 . The results suggest that the inhibitory capacity of antiPfl55 antibodies was unrelated to the geographic origin of the parasites giving rise to their formation. IgG fractions from the serum of the donors A or N were affinity purified on F32 (Table 4 ). The affinity-purified antibodies from both donors had the same high reinvasion inhibition titers when tested on either F32-or Thail-infected erythrocytes. In the latter case IgG and parasites were derived from the same patient (donor N).
Activities of antibodies of restricted specificities. Although results of all the experiments described above suggest that Pfl55 is antigenically invariant, they do not rigorously prove this, since the antibodies used were polyclonal and, with a few exceptions, were derived from donors who have had repeated P. falciparum infections. For this reason, similar experiments were performed with antibodies with restricted specificities. The following reagents were used: (i) a human monoclonal IgM antibody (33G2) that reacted with an epitope in the C-terminal repeat region of Pfl55 (36) ; (ii) a mouse monoclonal antibody to the synthetic octapeptide Glu-Glu-Asn-Val-Glu-His-Asp-Ala conjugated with keyhole limpet hemocyanin (Ruangjirachuporn et al., submitted); (iii) an oligoclonal IgG preparation obtained from a rabbit immunized with a linear dimer of the synthetic peptide Glu-GluAsn-Val also conjugated with keyhole limpet hemocyanin (4) . These amino acid sequences are major antigenic structures of Pf155 (1, 3, 4) , in which they occur as tandemly arranged repeats in the C-terminal part of the molecule (14) .
When tested by immunoblotting of SDS-PAGE-separated lysates of F32 merozoites or concentrated supernatants of F32 in vitro cultures, all these reagents give a strong staining of Pfl55 and a weaker staining of a few faster-migrating bands believed to be breakdown products of Pf155 (3, 4, 36) . When tested on merozoite lysates from additional strains (Thail, IMTM22/7G8), the banding pattern was the same as that obtained with F32, indicating that Pfl55 in all three lysates was similar with regard to both antigenicity and size (Fig. 3) . The same results were obtained when lysates of F32 and the Honduran clone HB3 were probed with 33G2 (data not shown).
When tested by the EMIF assay with parasites from different parts of the world, all three antibody reagents give the typical Pfl55-associated staining of the membrane of ring-infected erythrocytes (28) . This is shown in Fig. 4 for a Liberian isolate, with antibodies from the Liberian donor A (Fig. 4) (4, 29, 36) . In those experiments the inhibitory titer of the human monoclonal antibody 33G2 was 5 to 10 times lower than that of the polyclonal human preparations enriched in anti-Pfl55 antibodies (36) , while that of the antibodies against synthetic peptides was from 10 to 100 times lower but yet highly significant (3, 4) . This also held true when 33G2 was tested for reinvasion inhibition of merozoites from two different P. falciparum strains (F32, Thail; Fig. 5) . Similarly, in a separate experiment, the mouse monoclonal antibody to the synthetic octapeptide had 50% reinvasion inhibition titers of 38 and 34 ,ug/ml when tested on F32 and IMTM22/7G8, respectively (data not shown).
DISCUSSION
In this investigation, no antigenic diversity was detected when fresh P. falciparum isolates as well as different laboratory strains, including a number of cloned lines, were tested for their reactivity with anti-Pfl55 antibodies in human serum samples of malaria-exposed donors from different parts of the world. The major test to demonstrate this was a modified immunofluorescence test, in which Pfl55 was detected in the membranes of recently infected erythrocytes. Although other plasmodial antigens than Pfl55 may be expected to be present on the surface of such erythrocytes (19) , Pfl55 is the major antigen giving the typical erythrocyte surface staining seen in the EMIF assay (28, 39 Glu-Glu-Asn-Val-Glu-His-Asp-Ala (lanes 1 to 3) or the human monoclonal antibody 33G2 (culture supernatant diluted 1:25; lanes 4 to 6). For details see Fig. 1 legend and the text.
that the Pfl55 that was present in four different P. falciparum strains did not display any significant differences in size. Thus, Pfl55 is distinct from the S antigens which are similar with respect to heat stability and solubility (28, 41) but exhibit considerable serological diversity as well as size variation (2, 22, 42) , most likely reflecting the existence of allelic genes encoding antigens which differ in their immunodominant amino acid sequences (12, 15) .
Antibodies to Pfl55 have previously been shown to be very efficient inhibitors of reinvasion of erythrocytes by F32 merozoites in vitro (39) . Fab fragments of these antibodies inhibited almost as efficiently as intact IgG, indicating that reinvasion inhibition is due to antibody blocking of some biologically important sites on the antigen rather than to merozoite agglutination (29 4 . EMIF assay of glutaraldehyde-fixed and air-dried monolayers of erythrocytes from a Liberian patient infected with P. falciparum and stained with IgG from Liberian donor A (a), human monoclonal antibody 33G2 (b), mouse monoclonal antibody to the synthetic octapeptide Glu-Glu-Asn-Val-Glu-His-Asp-Ala (c), or rabbit oligoclonal antibody to the synthetic octapeptide Glu-Glu-Asn-Val-Glu-GluAsn-Val (d). The parasite nuclei were counterstained with ethidium bromide. Scale, 1:2,000.
the EMIF assay. They also inhibited reinvasion by F32 merozoites at very high titers, indicating that the corresponding sequences are accessible for antibody binding by the antigen in its native state (3, 30) . Similar results were obtained with a fraction of mouse or rabbit antibodies raised against synthetic oligopeptides of the same sequences (4; Ruangjirachuporn et al., submitted).
To further investigate antigenic diversity of Pfl55 from different isolates, we used a mouse monoclonal antibody to the octapeptide Glu-Glu-Asn-Val-Glu-His-Asp-Ala and an (18) . This conservation of the immunodominant repeats in Pfl55 is in contrast to the polymorphism found in immunodominant amino acid repeats in several other P. falciparum antigens (24, 27) . However, results of neither the DNA studies nor the results reported here exclude the existence of a minor antigenic diversity in Pfl55 structures outside the immunodominant repeats. Further investigations will be required to establish this.
